Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
(EAST2 Trial)
Recruiting in Palo Alto (17 mi)
+9 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Broncus Medical Inc
No Placebo Group
Trial Summary
What is the purpose of this trial?
The Archimedes System is an image-guided navigation system used to access tissue samples in the lungs. This study is being conducted to confirm the performance of the Archimedes System in patients who are scheduled for standard bronchoscopy to diagnose highly suspicious lung cancer or metastatic disease. Navigation to and sampling of the patient's lung cancer tumor is conducted.
Eligibility Criteria
Inclusion Criteria
Age 21-75 years at screening
Highly suspicious pulmonary nodule(s), defined as distinct nodule with a diameter of ≥8mm in its largest dimension
No known endobronchial tumor Tumor located anywhere in parenchymal tissue >1 cm from pleura and accessible bronchoscopically through a POE.
See 3 more
Treatment Details
Interventions
- Archimedes System (Navigation System)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: -Navigation and tissue samplingExperimental Treatment1 Intervention
Guided bronchoscopic navigation and lung tissue sampling using the Archimedes System
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of PennsylvaniaPhiladelphia, PA
Cancer Treatment Centers of America at Southwestern Regional Medical CenterTulsa, OK
Temple University HospitalPhiladelphia, PA
Duke UniversityDurham, NC
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Broncus Medical IncLead Sponsor